Daklinza Coupon & Prices

Is NiceRx a Daklinza coupon provider?

At NiceRx, we help eligible individuals access the Daklinza patient assistance program. This means that we are not a Daklinza coupon, a Daklinza discount card, or a Daklinza copay card provider. We do not offer any medication trial offers, or free Daklinza samples.

Daklinza patient assistance program

Patient assistance programs are typically sponsored by pharmaceutical companies and provide free or discounted medications to individuals with low income who are uninsured or under-insured and meet the eligibility criteria that vary by program. There are currently no known patient assistance programs for this medication.

Can NiceRx help me get Daklinza cheaper if I have insurance?

How much does Daklinza cost without insurance?

Daklinza costs without insurance will vary depending on how much you buy and the retailer you buy it from. If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.

How much does Daklinza cost with insurance?

The copay of Daklinza will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.

What is Daklinza?

Daklinza (daclatasvir) is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Bristol Myers Squibb (BMS). It is a direct-acting antiviral agent used to stop chronic hepatitis C virus (HCV) from multiplying in your body. It is used in combination with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 HCV infections. Daklinza has also been used to treat people with hepatitis C after liver transplantation.

What doses of Daklinza are available?

Daklinza is available in tablet form, in the following doses: 30 mg, 60 mg, and 90 mg tablets.

Take 60 mg orally once daily with or without food in combination with sofosbuvir with or without ribavirin for 12 weeks. Reduce the dose to 30 mg once daily with strong CYP3A inhibitors and increase the dose to 90 mg once daily with moderate CYP3A inducers.

The recommended regimen and duration of treatment for Hepatitis C Genotype 1:

• Without cirrhosis – daclatasvir plus sofosbuvir combination therapy for 12 weeks
• Compensated cirrhosis (Child-Pugh A) – daclatasvir plus sofosbuvir for 12 weeks
• Decompensated cirrhosis (Child-Pugh B or C) cirrhosis -daclatasvir plus sofosbuvir plus ribavirin for 12 weeks
• Posttransplant – daclatasvir plus sofosbuvir plus ribavirin for 12 weeks

The recommended regimen and duration of treatment for Hepatitis C Genotype 3:

• Without cirrhosis – daclatasvir plus sofosbuvir for 12 weeks
• Compensated (Child-Pugh A) or decompensated (Child-Pugh B or C) cirrhosis – daclatasvir plus sofosbuvir plus ribavirin for 12 weeks
• Posttransplant – daclatasvir plus sofosbuvir plus ribavirin for 12 weeks

See the full prescribing information for the complete boxed warning and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.

Daklinza active ingredients

Daklinza contains daclatasvir, an NS5A inhibitor as the active ingredient.

Daklinza side effects

The most common side effects of Daklinza in clinical trials include:

• Headache and fatigue
• Anemia
• Nausea

In rare instances, Daklinza can cause more serious side effects. These can include:

• Risk of Hepatitis B virus reactivation
• Bradycardia when taken with sofosbuvir and amiodarone, especially in patients receiving beta-blockers or those with cardiac comorbidities or advanced liver disease

Your doctor will assess the benefits of using Daklinza against your risk of adverse effects. Patients are encouraged to report negative side effects or adverse reactions to Daklinza to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Daklinza drug interactions

Daklinza can interact with other medications. These include:

• Strong inhibitors of CYP3A – clarithromycin, itraconazole, ketoconazole, ritonavir
• Strong inducers of CYP3A – phenytoin, carbamazepine, rifampin, and St. John’s wort
• Moderate CYP3A inducers – bosentan, dexamethasone

This list is not exhaustive and other prescription drugs may interact with Daklinza. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Daklinza contraindications

You should not use Daklinza if you:

• Are allergic to the active ingredient daclatasvir
• Are allergic to any of the other ingredients in Daklinza
• Are pregnant or are planning to become pregnant

Talk to your doctor before using Daklinza if you:

• Are taking any of the medications that could interact with Daklinza
• Have hepatitis B
• Have liver problems other than hepatitis C
• Have had a liver transplant
• Have diabetes
• Have heart disease
• Use blood thinners
• Are breastfeeding or are planning to breastfeed – It is unknown if daclatasvir passes into breast milk

Daklinza generic

Daklinza is the trademark brand name for daclatasvir manufactured by Bristol Myers Squibb (BMS). A generic version of daclatasvir is OR is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Daklinza savings through NiceRx.

Related medications

• Sovaldi
• Vosevi